The project covers medical, health and infectious disease prevention and control. Among them, the "one billion level respiratory system infectious disease vaccine industry base construction" project has attracted much attention. Respiratory infectious disease is the respiratory system disease clinical research center and one of the main research direction of state key laboratory of respiratory disease, years of study on etiology of respiratory infectious diseases and epidemiology, clinical diagnosis, treatment and so on basic and clinical research accumulated a lot of achievements and experience. The south China vaccine and its new VLPs vaccine platform are the core components of the contract.
NEWS
Contact us
Add:2nd Floor, Building C6, Science and Technology Enterprise Accelerator, Guangzhou Development Zone, No. 11, Kaiyuan Avenue, Guangzhou, China
Tel:020-89856010
Code:510663
Fax:020-89856019
Copyright © 2018-2022,www.gdscvc.com,All rights reserved South China Vaccine Corporation Limited.